Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neurofibromatosis 1 2Neoplasms 2Smoking Cessation 1Smoking 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Cognition Disorders 1Carcinoma, Hepatocellular 1Cancer Pain 1Breast Neoplasms 1Bone Neoplasms 1Anxiety Disorders 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1Agnosia 1Abdominal Pain 1

Interventions

Cisplatin 150Radiotherapy 121Cetuximab 96Docetaxel 60Fluorouracil 56Paclitaxel 45Radiotherapy, Intensity-Modulated 41Carboplatin 40pembrolizumab 34Surveys and Questionnaires 22Erlotinib Hydrochloride 19Nivolumab 18Immunohistochemistry 16Gefitinib 16Drug Therapy 16Gemcitabine 14Pemetrexed 13Gene Expression Profiling 13durvalumab 12Chemotherapy, Adjuvant 12Radiation 11Filgrastim 11Bevacizumab 11Surgical Procedures, Operative 10Polymerase Chain Reaction 10Amifostine 10Celecoxib 9Capecitabine 9Standard of Care 8Neoadjuvant Therapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Head and Neck Neoplasms × Transcranial Direct Current Stimulation × Clear all
NCT02366611 2021-01-22

Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer

University of Michigan

Phase NA Completed
11 enrolled 9 charts
Head & Neck

Cancer Pain, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡